Timothy R. Walsh is Professor of Medical Microbiology at the University of Oxford, where he co-established the Ineos Oxford Institute of Antimicrobial Research (IOI). At IOI, he serves as the Director of Biology. He also functions as the Independent Chief Scientific Consultant at the International Centre for Antimicrobial Resistance Solutions (ICARS). Prof. Walsh has led numerous international research collaborations across South Asia, SE Asia, China, and Africa. Currently, he leads several large international studies examining the clinical and economic burden of AMR in low-and middle-income countries (LMICs). His work focuses on understanding AMR transmission patterns between humans, animals, and the environment – a One Health approach. More specifically, the Walsh Lab’s key interests include: 1. The use of antimicrobials in animals and its impact on human clinical failures, 2. The drivers of AMR across all One Health sectors, 3. Causes and management of AMR neonatal sepsis and stillbirths in LMICs, and 4. The clinical and economic burden of AMR in LMICs. Their most recent publications may be found in in
Anu Kantele is Professor of Infectious Diseases at the University of Helsinki, Senior Medical Officer at Helsinki University Hospital, and Head of the Meilahti Vaccine Research Center (MeVac), HUS and UH. The Kantele group’s research centres on antimicrobial resistance (AMR); intestinal microbes; the spread of microbes across borders by travellers and migrants; travellers’ diarrhoea; diarrhoea in low- and middle-income countries (LMICs); urinary tract infections; returning travellers; tropical diseases; vaccinations; and infection immunology. Many of these themes share a common denominator: the intestinal microbiota and the host.
Claas Kirchhelle is a historian of 'bugs and drugs' and works as an Associate Professor (chargé de recherche) for the French National Institute of Health and Medical Research (INSERM), at the Paris CERMES3 Unit. His multi-award-winning interdisciplinary research focuses on the history of infectious disease, vaccines, antibiotics, bacteriophages, and microbial environments. In addition, engaging policy-makers and non-academic publics with expert consultancies, policy reports, and critically-acclaimed exhibitions is an important part of his work. Dr Kirchhelle’s publications include nominated and prize-winning books – such as Pyrrhic Progress – Antibiotics in Anglo-American Food Production (1949-2013), and his most recent publications have appeared in
Dan I. Andersson is the director of the Uppsala Antibiotic Center and Professor in Medical Bacteriology at the Uppsala University. His research addresses the mechanisms and dynamics of evolution in bacteria and how various factors such as the extent and type of genetic variation, strength of selection pressures, compensatory mutations and population dynamics affect the tempo and mode of adaptive evolution. Among his many achievements, Prof. Andersson is an elected fellow of the Royal Swedish Academy of Sciences, the American Academy of Microbiology, the European Academy of Microbiology and the Royal Society of Sciences at Uppsala. His recent work has been published in
Barth F. Smets is Professor at the department of Biological and Chemical engineering at Aarhus University, Denmark. He is educated at the interface of Engineering (Environmental & Biochemical Engineering) and Life Sciences (Microbiology & Agronomic Sciences) with previous employment at academic institutions in Europe, USA, and Asia. He has coordinated large research groups investigating and developing bioprocesses and microbiomes in water and environmental engineering applications. Furthermore, he has experience managing multi-institutional and multi-disciplinary R&D projects, and his interests lie in facilitating and evaluating mission-oriented R&D and engineering projects to help solve environmental and societal challenges. Prof. Smets is also member of the Technical Advisory Board of the International Centre for Antimicrobial Resistance Solutions (ICARS), where he lends his expertise to support the implementation of research projects on AMR mitigation, especially those with a strong animal health/environment component. His recent publications include